WADA 2026 Annual Report: Testing Volume Still Rising, but Momentum Slows — 45% of Compliance Failures Sit in Sample Collection

Busan, South Korea, December 2026. Inside the hall of the World Conference on Doping in Sport, delegates raise their cards to adopt the 2027 edition of the World Anti-Doping Code. There is no confetti, no light show. Only a deadline written into the document: 1 January 2027.

Around the same period, the World Anti-Doping Agency published its 2026 Annual Report. The statistics open with two figures: 288,865 samples collected in 2026 and 297,965 in 2026. That is 9,100 additional samples, or 3.2 percent.

Place 3.2 percent beside the previous year's growth, 12.5 percent from 2026 to 2026, and the picture changes. The system is still expanding capacity, but the curve has clearly flattened. For swimming, an event group that consistently ranks among the highest in sample volume across the Olympic system, the slope matters more than the total.

WADA does not walk the pool deck

WADA was created in 2026 and is headquartered in Montreal, Canada. It does not personally hold test tubes on any pool deck. Sample collection belongs to national anti-doping organisations and international federations, with World Aquatics governing swimming. WADA sets standards, accredits laboratories, maintains the ADAMS database and monitors whether signatories comply.

Its funding model is unusual. The budget is split evenly between the Olympic Movement and the world's governments. That means a body auditing sport's integrity depends on the financial goodwill of the very states with the largest teams. The structure was never a problem until invoices went unpaid.

The World Anti-Doping Code was first adopted in Copenhagen in 2026 and took effect in 2026, then revised in cycles: 2026, 2026, 2026 and now 2027. Each revision forces the entire system to relearn the rules, rewrite procedures, retrain staff and reconfigure software. For smaller federations, that is a staffing problem, not a question of will.

A curve that is flattening

The report presents a test-volume series running from 2026 to 2026. The interesting part is not the peak but the slope. From 2026 to 2026, samples rose 12.5 percent. From 2026 to 2026, growth was only 3.2 percent. Moving from 288,865 to 297,965 samples means roughly 9,100 more tests worldwide in a single year.

Across a network of more than 200 national anti-doping organisations, 9,100 extra samples is not a surge. It resembles a standard pool opening a few extra lanes during peak hours. Operationally meaningful, but not a change in the flow of people.

Meanwhile, the adverse analytical finding rate, meaning samples returning a positive result for a prohibited substance or method, stayed almost motionless. Three consecutive years: 0.77 percent, 0.80 percent and 0.78 percent. The band of variation is roughly 0.03 percentage points. In statistical terms, a flat series like this usually reads as a stable baseline signal rather than noise.

What does a flat curve actually mean? If the numerator rises while the detection rate holds, there are two plausible explanations, and the report cannot separate them. First, the prevalence of doping in the athlete population may genuinely be stable. Second, the system may be extending coverage to a population with a similar positivity level, leaving the aggregate rate unchanged despite a broader net. Neither is bad news, but they point to opposite policy conclusions.

A time inconsistency worth remembering

The report carries the 2026 label, yet most testing data refer to 2026 and 2026, while the budget is presented on a 2026 income year. This is most likely a one-year publication lag, common among international organisations. Still, for anyone citing the figures, the gap matters: quote without a clear date reference and you may attach a 2026 number to a 2026 event.

In sports data work, I check dates before I check error margins. A correct number placed in the wrong year causes more damage than a wrong number placed in the right one.

Forty-five percent of failures sit in sample collection

The compliance section is where the concern lies. Audits show average non-conformities falling from 25.5 to 20. This is presented as a win. But only nine audits were carried out, a sample far too small to support a global trend claim.

Deeper in the structure, the problem looks worse. About 45 percent of non-conformities concern sample collection, meaning the on-site process of gathering samples rather than laboratory analysis. This category rose 11 percent year on year, and 23 percent of those findings were classified as critical.

That is telling. A system can have modern laboratories and good equipment, yet if collectors are untrained, if forms are incomplete, if samples travel at the wrong temperature, the entire chain of evidence collapses. In doping litigation, losses in court usually begin with a procedural link, not with a blood sample.

An 8.3 million dollar gap and two big names

The financial section gets the least attention and carries the most weight. WADA recorded a shortfall of 8.3 million US dollars against plan. The United States has not paid roughly 3.8 million dollars of its contribution, while Russia remains in arrears by about 3.9 million dollars. Against that, the report still shows a net surplus of 1.2 million dollars.

The coexistence of a large shortfall and a net surplus says a lot about operations. It suggests aggressive cost control or deferred spending to stay balanced. For an agency whose main output is testing capacity, cost control can translate into slower sample coverage in the near term. That is precisely why the 3.2 percent figure at the top of the report should not be read in isolation.

A question emerges that the report does not answer, and perhaps cannot: who watches the watchers, when the resources for watching depend on the states being watched?

WADA is changing jobs: from testing to investigations

Another directional signal sits in the investigations section. The report records more than 250 investigation operations, 88 laboratories dismantled and over 90 tonnes of substances seized, with language describing a shift from predominantly traditional athlete drug testing toward investigations and prevention.

Strategically, the direction is sound. Testing detects after the fact, while investigations can cut a supply chain before a substance reaches an athlete. But it also changes resource allocation. Money spent on investigations is money not spent on mass sample coverage. In coverage-heavy sports such as swimming, where a national championship can involve hundreds of athletes across dozens of events, that shift may reduce testing density in smaller federations.

In parallel, WADA and its Athlete Council ran an athlete-centred consultation involving more than 600 athletes and commissions from over 60 countries and more than 70 sports. That is a notable legitimacy-building step. What the report does not say is whether athlete input actually changed the substance of the Code, or remained a formal consultation exercise.

The contrarian read: the headline says one thing, the data another

The headline framing of expanded sample testing suggests a system accelerating. The data show a system maintaining momentum at a decelerating rate. This is a familiar distortion in sports media: using the absolute number in the headline and ignoring its derivative.

The second problem is subtler. A stable adverse finding rate near 0.78 percent is easily read as proof that the system has the situation under control. That reading ignores a statistical fact: the detection rate is a product of both prevalence and detection capacity. Separating the two requires data by substance class, sport, country and season. An annual report does not provide that granularity.

The third problem is arguably the most important: the compliance picture is moving in two opposite directions. Average non-conformities fell, described as progress. Yet the specific sample-collection failure group rose 11 percent and accounted for 45 percent of all findings. A system can look better on paper while weakening at the operational level.

What this means for swimming

Having covered swimming for years, what stands out is how sample-intensive the sport is. A swimmer may race four to six events at a single meet, and every finish is a potential selection point for testing. Relay events multiply the number of athletes involved. Any change in the system's collection capacity therefore shows up in swimming earlier than in many other sports.

Recent cases illustrate that dependence. Australian swimmer Shayna Jack received a long suspension after an out-of-competition positive result for Ligandrol, had the sanction reduced through appeal, and returned to the pool to contribute to Australian relay medals. In another case, Chinese swimmer Sun Yang went through multi-year proceedings with an initially severe sanction that was later adjusted before he returned to competition. In both instances, the final outcome often hinged not on the analytical result itself but on the quality of the procedural chain: records, witnesses, sample storage.

A badly collected sample can become a multi-year case, and a multi-year case can dissolve an athlete's career before a tribunal ever rules. That is why the 11 percent rise in collection failures matters more than any headline sample total.

I have watched this process backstage at swim meets. Nothing dramatic happens. A doping control officer escorts the athlete from the pool to the testing room, a bottle of water, a form, a signature, a seal. Nobody films that segment, and nobody wants it as a headline. Yet that segment determines the legal value of everything that follows.

In 2026, when pools closed and the global calendar collapsed, I was in Melbourne working with a small biomechanics research group. We analysed movement data from hurdlers, and what I remember is not the numbers but the feeling of sitting in front of a chart where the missing months were blank holes. Sports data does not refill itself. It drains slowly, and by the time activity resumes, the ability to compare against one's own past is gone. The 2026 to 2026 series in the WADA report carries a similar scar, at a far larger scale.

Worth adding is the case of 23 Chinese swimmers whose samples from 2026 returned positives for trimetazidine, revealed in April 2026, with WADA accepting an environmental contamination explanation. International reaction was strong, prompting an independent review by a former Swiss attorney general, published in September 2026, which concluded WADA's handling contained no serious impropriety. That episode shows something annual percentages cannot capture: public trust in anti-doping is built not by sample counts but by the transparency of the smallest procedures.

What to watch over the next two years

The 1 January 2027 milestone is fixed, already dated, and highly useful for federation planning. The period until then is a compliance gap: old rules still apply, new rules are not yet in force, and national agencies have limited internal incentive to invest early.

Three signals will matter in the coming cycle. First, the growth rate in the next annual report: if 3.2 percent turns negative, that signals eroding operational capacity rather than a new strategic priority. Second, the adverse finding rate: above roughly 0.85 percent, it becomes necessary to ask whether prevalence or target selection has changed. Third, the contribution status of major states: once non-payment becomes precedent, the funding model of the anti-doping system itself is at risk.

For swimming, the most direct consequence is not at world championships, where sample volume remains relatively assured. It is at national and regional meets, where smaller anti-doping organisations must choose between complying with a new code and paying for enough out-of-competition tests. A medal at a junior continental championship can be decided by something no spectator sees: whether that federation still has the budget to walk onto a pool deck on a Tuesday morning.

Data hurts in its own quiet way. A decelerating curve does not shout like a scandal. It simply tilts downward, a few percentage points a year, until people realise that what is shrinking is not a figure but the ability to guarantee that the winner won clean.

In sport, every record is a confirmed hypothesis, and every defeat is an equation waiting to be solved again. But there is one category of equation that cannot be solved incorrectly: the one about who is entitled to believe the result on the scoreboard. If the new code takes effect in 2027 without enough money and enough people to enforce it, that date will remain a beautiful line in a beautiful document. And the ultimate loser will still be the athlete in lane four, training every morning without knowing that the system protecting them is slowing by a few percent each year.